Features, genetics and their correlation in Jalili syndrome: a systematic review.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 30705057.
- Also identified by DOI 10.1136/jmedgenet-2018-105716.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Jalili syndrome is a rare genetic disorder first identified by Jalili in Gaza. Amelogenesis imperfecta and cone-rode dystrophy are simultaneously seen in Jalili syndrome patients as the main and primary manifestations. Molecular analysis has revealed that the <i>CNNM4</i> gene is responsible for this rare syndrome. Jalili syndrome has been observed in many countries around the world, especially in the Middle East and North Africa. In the current scoping systematic review we searched electronic databases to find studies related to Jalili syndrome. In this review we summarise the reported clinical symptoms, <i>CNNM4</i> gene and protein structure, <i>CNNM4</i> mutations, attempts to reach a genotype-phenotype correlation, the functional role of <i>CNNM4</i> mutations, and epidemiological aspects of Jalili syndrome. In addition, we have analysed the reported mutations in mutation effect prediction databases in order to gain a better understanding of the mutation's outcomes.
Medical subject headings
- Amelogenesis Imperfecta
- Cone-Rod Dystrophies
- Genetic Association Studies
- Genetic Predisposition to Disease
- Phenotype